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Background: The effect of transcatheter aortic valve implantation (TAVI) on left and right ventricular (LV and RV) function has not yet been 
described in detail. Our aims were to evaluate systolic global and regional bi- ventricular function by echocardiography and tissue Doppler before 
and after TAVI. 
Method: 20 patients (7 male), median age 84 (range 60-90) years, who underwent transapical (13) or transfemoral (7) TAVI were examined with 
echo- Doppler before and 8 weeks after TAVI. In addition to conventional echocardiographic parameters, systolic atrioventricular plane displacement 
(AVPD) at standard sites and peak systolic myocardial velocity (PSV) by pulsed tissue Doppler at basal RV free wall, LV lateral wall and septum 
were recorded. Pre-procedural EuroScore was 22 (14-27) %. Three patients were not available for follow-up due to non-cardiac reasons. Data are 
expressed as median and analyzed by Wilcoxon signed rank test, p<0.05. 
Results: Procedural success rate was 100%, 30- and 120- day mortality 5% and 10%, respectively. Post-TAVI, effective orifice area was 1.4 (1.1-
1.6) cm2 and mean gradient 12 (8-14) mmHg. Ejection fraction, posterior wall thickness and LV diastolic and systolic dimensions were unchanged 
at follow-up. An increase in LV lateral AVPD was observed. 
Conclusion: Eight weeks after TAVI, regional LV lateral systolic function had improved. The global LV function was unchanged. RV and septal systolic 
function remained unaltered, seemingly unaffected by the procedure. 
Variable (n) Pre-TAVI (20) Post-TAVI (15) ΔPost-pre p
Fractional Shortening (%) 34 (29-39) 38 (29-42) 5 (-4-8) 0.48
Ejection Fraction (n)
>50% /<50%
17/3 13/1* --- 0.32
Septal Wall Thickness (mm) 14 (11-17) 12 (10-15) -2.0 (-4.0-0.3) 0.01
Left Atrial Area (cm2) 26 (22-33) 26 (23-30) -2.0 (-6.0-0.3) 0.03
AVPD-lateral (mm) 8 (7-10) 9 (8-11) 2 (0-3) 0.003
AVPD-septal (mm) 6 (5-7) 6 (5-8) 0(0-2) 0.09
PSV-lateral (cm/s) 4.0 (3.0-5.8) 4.0(3.5-6.0) 0.0 (-0.3-2,5) 0.20
PSV-septal (cm/s) 3.5 (3.0-4.0) 4.0 (3.0-6.0) 0.5 (0.0-2.0) 0.13
RV-AVPD (mm) 16 (10-20) 17 (12-17) -1 (-4-6) 0.80
RV-PSV (cm/s) 8.0 (6.2-10.0) 9.0 (6.5-11.5) -1.0 (-3.0-0.5) 0.08
* Post-EF not estimated in one patient with EF <50% pre-TAVI due to suboptimal image quality.
